Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Hammerschlag

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|March 14, 1998
Antibody response to Chlamydia pneumoniae infection in children with respiratory illnessA Kutlin, P M Roblin, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|September 3, 1999
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection modelA Kutlin, P M Roblin, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|June 1, 1994
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniaeP M Roblin, G Montalban, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|July 1, 1994
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumoniaP M Roblin, G Montalban, M R Hammerschlag
Pediatric Infectious Disease|May 1, 1986
Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitisB L Congeni, J Bradley, M R Hammerschlag
The Pediatric Infectious Disease Journal|February 15, 2001
Failure to demonstrate Chlamydia pneumoniae in cardiovascular tissue from children with Kawasaki diseaseM R Hammerschlag, J Boman, A H Rowley
Journal of Clinical Microbiology|August 1, 1992
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniaeP M Roblin, W Dumornay, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|September 1, 1989
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)K Chirgwin, P M Roblin, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|September 26, 1997
In vitro activity of trovafloxacin against Chlamydia pneumoniaeP M Roblin, A Kutlin, M R Hammerschlag
Reviews of Infectious Diseases|March 1, 1989
Epidemiology of sexually transmitted diseases in rape victimsJ B Glaser, M R Hammerschlag, W M McCormack
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|March 14, 1998
Antibody response to Chlamydia pneumoniae infection in children with respiratory illnessA Kutlin, P M Roblin, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|September 3, 1999
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection modelA Kutlin, P M Roblin, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|June 1, 1994
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniaeP M Roblin, G Montalban, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|July 1, 1994
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumoniaP M Roblin, G Montalban, M R Hammerschlag
Pediatric Infectious Disease|May 1, 1986
Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitisB L Congeni, J Bradley, M R Hammerschlag
The Pediatric Infectious Disease Journal|February 15, 2001
Failure to demonstrate Chlamydia pneumoniae in cardiovascular tissue from children with Kawasaki diseaseM R Hammerschlag, J Boman, A H Rowley
Journal of Clinical Microbiology|August 1, 1992
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniaeP M Roblin, W Dumornay, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|September 1, 1989
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)K Chirgwin, P M Roblin, M R Hammerschlag
Antimicrobial Agents and Chemotherapy|September 26, 1997
In vitro activity of trovafloxacin against Chlamydia pneumoniaeP M Roblin, A Kutlin, M R Hammerschlag
Reviews of Infectious Diseases|March 1, 1989
Epidemiology of sexually transmitted diseases in rape victimsJ B Glaser, M R Hammerschlag, W M McCormack
Pageof 10